StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)

Close on Nov 18, 2026Market cap $3.04BP/E –Yield –

Telix Pharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 338M, down 2.1% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025338M-2.1%
FY2024Dec 31, 2024345M+6.6%
FY2023Dec 31, 2023324M+4.2%
FY2022Dec 31, 2022311M–

More Telix Pharmaceuticals figures

See a number that looks wrong?